I agree that this site is using cookies. You can find further informations here.
X
Melgar, Katelyn
6  results:
Search for persons X
?
1

81030 Utilizing a synergistic drug combination to target re..:

Jones, LaQuita ; Melgar, Katelyn ; Hoyt, Scott...
Journal of Clinical and Translational Science.  5 (2021)  s1 - p. 100-100 , 2021
Link: https://doi.org/10.1017/..
 
?
2

Deconstructing innate immune signaling in myelodysplastic s..:

Varney, Melinda E. ; Melgar, Katelyn ; Niederkorn, Madeline...
Experimental Hematology.  43 (2015)  8 - p. 587-598 , 2015
Link: https://doi.org/10.1016/..
 
?
3

Targeting AML-associated FLT3 mutations with a type I kinas..:

Jones, LaQuita M ; Melgar, Katelyn ; Bolanos, Lyndsey...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108888/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
4

Overcoming adaptive therapy resistance in AML by targeting ..:

Melgar, Katelyn ; Walker, Morgan M ; Jones, LaQuita M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985905/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
5

Deconstructing innate immune signaling in Myelodysplastic S..:

Varney, Melinda E ; Melgar, Katelyn ; Niederkorn, Madeline...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635673/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
6

81030 Utilizing a synergistic drug combination to target re..:

LaQuita Jones ; Katelyn Melgar ; Scott Hoyt...
https://www.cambridge.org/core/product/identifier/S2059866121006580/type/journal_article.  , 2021
Link: https://doi.org/10.1017/..
 
1-6